%0 Generic
%B J Med Econ
%D 2017
%P 555-564
%R 10.1080/13696998.2017.1284078
%T Estimated burden of cardiovascular disease and value-based price range for evolocumab in a high-risk, secondary-prevention population in the US payer context
%V 20